← All companies
CMMB
Chemomab Therapeutics Ltd.
$1.62
+0.09 +5.88%
Key statistics
from XBRL data in SEC filingsMarket cap
$932M
Revenue (TTM)
—
Net income (TTM)
-$8.99M
EPS (TTM)
$0.02
P/E ratio
90.0
Dividend yield
—
Free cash flow
-$11.1M
Cash
$7.56M
Total assets
$13.8M
Gross margin
—
52-week range
$1.35 – $4.20
Recent SEC filings
40 most recentAnnual, quarterly & current reports
6-K
Jul 8, 2026
6-K
Jun 2, 2026
6-K
May 14, 2026
6-K
May 6, 2026
6-K
Apr 28, 2026
20-F
Mar 23, 2026
6-K
Mar 20, 2026
6-K
Mar 19, 2026
6-K
Nov 21, 2025
6-K
Aug 22, 2025
6-K
Aug 14, 2025
6-K
Jul 25, 2025
6-K
Jul 1, 2025
6-K
May 27, 2025
6-K
May 15, 2025
6-K
Apr 15, 2025
20-F
Apr 4, 2025
6-K
Mar 27, 2025
6-K
Mar 20, 2025
6-K
Mar 3, 2025
6-K
Feb 19, 2025
6-K
Nov 18, 2024
6-K
Nov 14, 2024
6-K
Oct 11, 2024
6-K
Aug 21, 2024
6-K
Jul 25, 2024
6-K
Jun 12, 2024
6-K
May 9, 2024
6-K
May 8, 2024
6-K
May 3, 2024
20-F
Mar 28, 2024
6-K
Mar 7, 2024
6-K
Jan 3, 2024
6-K
Nov 9, 2023
6-K
Aug 14, 2023
6-K
Aug 8, 2023
6-K
Jul 3, 2023
8-K
Director or officer change
Jun 16, 2023
8-K
Director or officer change; Regulation FD disclosure
Jun 5, 2023
8-K
Results of operations (earnings release)
May 11, 2023